NEW YORK, July 17, 2023 /PRNewswire/ -- The effervescent tablet market size is projected to grow by USD 4.55 billion with a CAGR of 5.12% during the forecast period 2021 to 2026, according to Technavio. The growing competition in the market is compelling vendors to adopt various growth strategies such as promotional activities and spending on advertisements to improve the visibility of their services. Technavio report analyzes the market's competitive landscape and offers information on several market vendors including - ALPEX PHARMA SA, Amerilab Technologies Inc, Bayer AG, Bliss GVS Pharma Ltd., Bristol Myers Squibb Co., CHIESI Farmaceutici SpA, GlaxoSmithKline Plc, Herbalife International of America Inc, HERMES PHARMA GmbH, Natur Produkt Zdrovit Sp Z O O, Nestle SA, Novartis AG, Perrigo Co. Plc, Pfizer Inc., Reckitt Benckiser Group PLC, S. G. Biopharm Pvt. Ltd, SciTech, Swisse Wellness Pty Ltd., Vitabiotics Ltd., and Vovantis Laboratories. - Download Sample Report in minutes.
Effervescent Tablet Market Insights -
- Vendors: 15+, Including ALPEX PHARMA SA, Amerilab Technologies Inc, Bayer AG, Bliss GVS Pharma Ltd., Bristol Myers Squibb Co., CHIESI Farmaceutici SpA, GlaxoSmithKline Plc, Herbalife International of America Inc, HERMES PHARMA GmbH, Natur Produkt Zdrovit Sp Z O O, Nestle SA, Novartis AG, Perrigo Co. Plc, Pfizer Inc., Reckitt Benckiser Group PLC, S. G. Biopharm Pvt. Ltd, SciTech, Swisse Wellness Pty Ltd., Vitabiotics Ltd., and Vovantis Laboratories, among others
- Coverage: Parent market analysis; key drivers, major trends, and challenges; customer and vendor landscape; vendor product insights and recent developments; key vendors; and market positioning of vendors
- Segments: Type (Powder, Tablet, Granules, and Others) and Geography (North America, Europe, Asia, and Rest of World (ROW))
To understand more about the effervescent tablet market, request a sample report
Key Drivers - Increasing adoption of effervescent tablets among the aging population is one of the key factors driving market growth. This is due to the growing awareness among people of health-related products such as nutritional supplements. Furthermore, there is a rapid increase in the aging population, the signs of anti-aging include wrinkles, dark spots, dark circles, hyperpigmentation, and uneven skin tones. As a result, manufacturers of anti-aging products have started producing specific effervescent tablets for natural supplements like vitamin C to address the growing demand. These products can stimulate collagen production and are important for youthful skin. In addition, effervescent tablets are usually taken to complement various required nutrients which include vitamin D, calcium, iron, vitamin C, and others. Hence, these factors are expected to drive market growth during the forecast period.
Major Trends- The availability of supplements for youth and children in effervescent tablet form is a major trend in the market.
Significant Challenges- High sodium content in effervescent tablets is one of the significant factors restricting market growth.
The effervescent tablet market report provides critical information and factual data, with a qualitative and quantitative study of the market based on market drivers and limitations as well as prospects.
Why Buy?
- Add credibility to the strategy
- Analyzes competitor's offerings
- Get a holistic view of the market
- Grow your profit margin with Technavio- Buy the Report
What are the key data covered in this Effervescent Tablet Market report?
- CAGR of the market during the forecast period
- Detailed information on factors that will drive the growth of the effervescent tablet market between 2022 and 2026
- Precise estimation of the size of the effervescent tablet market and its contribution to the market with a focus on the parent market
- Accurate predictions about upcoming trends and changes in consumer behavior
- Growth of the effervescent tablet market across North America, Europe, Asia, and the Rest of the World (ROW)
- A thorough analysis of the market's competitive landscape and detailed information about vendors
- Comprehensive analysis of factors that will challenge the growth of effervescent tablet market vendors
Gain instant access to 17,000+ market research reports.
Technavio SUBSCRIPTION platform
Related Reports
The Tourette's syndrome drugs market size is estimated to grow by USD 598.85 million at a CAGR of 6.69% between 2022 and 2027. Furthermore, this report extensively covers market segmentation by product (antipsychotics and non-antipsychotics), distribution channel (offline and online), and geography (North America, Europe, Asia, and the Rest of the World (ROW)). Rising awareness about Tourette syndrome in individuals is a key factor driving the market growth during the forecast period.
The antiemetic drug market size is estimated to grow by USD 1,632.81 million at a CAGR of 6.47% between 2022 and 2027. Furthermore, this report extensively covers market segmentation by application (chemotherapy, surgery, gastroenteritis, and others), drug Class (5-hydroxytryptamine 3 (5-HT 3) receptor antagonist, dopamine antagonist, neurokinin-1 (NK 1) receptor antagonist, cannabinoid receptor antagonist, and others), and geography (North America, Europe, Asia, and the Rest of the World (ROW)). The increasing prevalence of nausea and vomiting is a key factor driving the market growth during the forecast period.
Effervescent Tablet Market Scope |
|
Report Coverage |
Details |
Base year |
2021 |
Historic period |
2017-2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 5.12% |
Market Growth 2022-2026 |
USD 4.55 billion |
Market structure |
Fragmented |
YoY growth 2022-2023 (%) |
5.1 |
Regional analysis |
North America, Europe, Asia, and the Rest of the World (ROW) |
Performing market contribution |
North America at 31% |
Key countries |
US, Germany, Switzerland, China, and India |
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
Key companies profiled |
ALPEX PHARMA SA, Amerilab Technologies Inc, Bayer AG, Bliss GVS Pharma Ltd., Bristol Myers Squibb Co., CHIESI Farmaceutici SpA, GlaxoSmithKline Plc, Herbalife International of America Inc, HERMES PHARMA GmbH, Natur Produkt Zdrovit Sp Z O O, Nestle SA, Novartis AG, Perrigo Co. Plc, Pfizer Inc., Reckitt Benckiser Group PLC, S. G. Biopharm Pvt. Ltd, SciTech, Swisse Wellness Pty Ltd., Vitabiotics Ltd., and Vovantis Laboratories |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Table of Contents
1 Executive Summary
- 1.1 Market Overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
- Exhibit 06: Executive Summary – Chart on Incremental Growth
- Exhibit 07: Executive Summary – Data Table on Incremental Growth
- Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 09: Parent market
- Exhibit 10: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 11: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 12: Market segments
- 3.3 Market size 2021
- 3.4 Market outlook: Forecast for 2021-2026
- Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
- Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
- 4.1 Five forces summary
- Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
- 4.2 Bargaining power of buyers
- Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
- 4.3 Bargaining power of suppliers
- Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
- 4.4 Threat of new entrants
- Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
- 4.5 Threat of substitutes
- Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
- 4.6 Threat of rivalry
- Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
- 4.7 Market condition
- Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Type
- 5.1 Market segments
- Exhibit 24: Chart on Type - Market share 2021-2026 (%)
- Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
- 5.2 Comparison by Type
- Exhibit 26: Chart on Comparison by Type
- Exhibit 27: Data Table on Comparison by Type
- 5.3 Powder - Market size and forecast 2021-2026
- Exhibit 28: Chart on Powder - Market size and forecast 2021-2026 ($ million)
- Exhibit 29: Data Table on Powder - Market size and forecast 2021-2026 ($ million)
- Exhibit 30: Chart on Powder - Year-over-year growth 2021-2026 (%)
- Exhibit 31: Data Table on Powder - Year-over-year growth 2021-2026 (%)
- 5.4 Tablet - Market size and forecast 2021-2026
- Exhibit 32: Chart on Tablet - Market size and forecast 2021-2026 ($ million)
- Exhibit 33: Data Table on Tablet - Market size and forecast 2021-2026 ($ million)
- Exhibit 34: Chart on Tablet - Year-over-year growth 2021-2026 (%)
- Exhibit 35: Data Table on Tablet - Year-over-year growth 2021-2026 (%)
- 5.5 Granules - Market size and forecast 2021-2026
- Exhibit 36: Chart on Granules - Market size and forecast 2021-2026 ($ million)
- Exhibit 37: Data Table on Granules - Market size and forecast 2021-2026 ($ million)
- Exhibit 38: Chart on Granules - Year-over-year growth 2021-2026 (%)
- Exhibit 39: Data Table on Granules - Year-over-year growth 2021-2026 (%)
- 5.6 Others - Market size and forecast 2021-2026
- Exhibit 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
- Exhibit 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
- Exhibit 42: Chart on Others - Year-over-year growth 2021-2026 (%)
- Exhibit 43: Data Table on Others - Year-over-year growth 2021-2026 (%)
- 5.7 Market opportunity by Type
- Exhibit 44: Market opportunity by Type ($ million)
6 Customer Landscape
- 6.1 Customer landscape overview
- Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
- 7.1 Geographic segmentation
- Exhibit 46: Chart on Market share by geography 2021-2026 (%)
- Exhibit 47: Data Table on Market share by geography 2021-2026 (%)
- 7.2 Geographic comparison
- Exhibit 48: Chart on Geographic comparison
- Exhibit 49: Data Table on Geographic comparison
- 7.3 North America - Market size and forecast 2021-2026
- Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
- Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
- 7.4 Europe - Market size and forecast 2021-2026
- Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
- Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
- 7.5 Asia - Market size and forecast 2021-2026
- Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
- Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
- 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
- Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- 7.7 US - Market size and forecast 2021-2026
- Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
- Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)
- 7.8 India - Market size and forecast 2021-2026
- Exhibit 70: Chart on India - Market size and forecast 2021-2026 ($ million)
- Exhibit 71: Data Table on India - Market size and forecast 2021-2026 ($ million)
- Exhibit 72: Chart on India - Year-over-year growth 2021-2026 (%)
- Exhibit 73: Data Table on India - Year-over-year growth 2021-2026 (%)
- 7.9 Germany - Market size and forecast 2021-2026
- Exhibit 74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
- Exhibit 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
- 7.10 Switzerland - Market size and forecast 2021-2026
- Exhibit 78: Chart on Switzerland - Market size and forecast 2021-2026 ($ million)
- Exhibit 79: Data Table on Switzerland - Market size and forecast 2021-2026 ($ million)
- Exhibit 80: Chart on Switzerland - Year-over-year growth 2021-2026 (%)
- Exhibit 81: Data Table on Switzerland - Year-over-year growth 2021-2026 (%)
- 7.11 China - Market size and forecast 2021-2026
- Exhibit 82: Chart on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 83: Data Table on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 84: Chart on China - Year-over-year growth 2021-2026 (%)
- Exhibit 85: Data Table on China - Year-over-year growth 2021-2026 (%)
- 7.12 Market opportunity by geography
- Exhibit 86: Market opportunity by geography ($ million)
8 Drivers, Challenges, and Trends
- 8.1 Market drivers
- 8.2 Market challenges
- 8.3 Impact of drivers and challenges
- Exhibit 87: Impact of drivers and challenges in 2021 and 2026
- 8.4 Market trends
9 Vendor Landscape
- 9.1 Overview
- 9.2 Vendor landscape
- Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
- 9.3 Landscape disruption
- Exhibit 89: Overview on factors of disruption
- 9.4 Industry risks
- Exhibit 90: Impact of key risks on business
10 Vendor Analysis
- 10.1 Vendors covered
- Exhibit 91: Vendors covered
- 10.2 Market positioning of vendors
- Exhibit 92: Matrix on vendor position and classification
- 10.3 Bayer AG
- Exhibit 93: Bayer AG - Overview
- Exhibit 94: Bayer AG - Business segments
- Exhibit 95: Bayer AG - Key offerings
- Exhibit 96: Bayer AG - Segment focus
- 10.4 Bristol Myers Squibb Co.
- Exhibit 97: Bristol Myers Squibb Co. - Overview
- Exhibit 98: Bristol Myers Squibb Co. - Product / Service
- Exhibit 99: Bristol Myers Squibb Co. - Key offerings
- 10.5 CHIESI Farmaceutici SpA
- Exhibit 100: CHIESI Farmaceutici SpA - Overview
- Exhibit 101: CHIESI Farmaceutici SpA - Product / Service
- Exhibit 102: CHIESI Farmaceutici SpA - Key offerings
- 10.6 GlaxoSmithKline Plc
- Exhibit 103: GlaxoSmithKline Plc - Overview
- Exhibit 104: GlaxoSmithKline Plc - Business segments
- Exhibit 105: GlaxoSmithKline Plc - Key offerings
- Exhibit 106: GlaxoSmithKline Plc - Segment focus
- 10.7 HERMES PHARMA GmbH
- Exhibit 107: HERMES PHARMA GmbH - Overview
- Exhibit 108: HERMES PHARMA GmbH - Product / Service
- Exhibit 109: HERMES PHARMA GmbH - Key offerings
- 10.8 Novartis AG
- Exhibit 110: Novartis AG - Overview
- Exhibit 111: Novartis AG - Business segments
- Exhibit 112: Novartis AG - Key offerings
- Exhibit 113: Novartis AG - Segment focus
- 10.9 Perrigo Co. Plc
- Exhibit 114: Perrigo Co. Plc - Overview
- Exhibit 115: Perrigo Co. Plc - Business segments
- Exhibit 116: Perrigo Co. Plc - Key offerings
- Exhibit 117: Perrigo Co. Plc - Segment focus
- 10.10 Pfizer Inc.
- Exhibit 118: Pfizer Inc. - Overview
- Exhibit 119: Pfizer Inc. - Product / Service
- Exhibit 120: Pfizer Inc. - Key news
- Exhibit 121: Pfizer Inc. - Key offerings
- 10.11 Reckitt Benckiser Group PLC
- Exhibit 122: Reckitt Benckiser Group PLC - Overview
- Exhibit 123: Reckitt Benckiser Group PLC - Business segments
- Exhibit 124: Reckitt Benckiser Group PLC - Key offerings
- Exhibit 125: Reckitt Benckiser Group PLC - Segment focus
- 10.12 S. G. Biopharm Pvt. Ltd
- Exhibit 126: S. G. Biopharm Pvt. Ltd - Overview
- Exhibit 127: S. G. Biopharm Pvt. Ltd - Product / Service
- Exhibit 128: S. G. Biopharm Pvt. Ltd - Key offerings
11 Appendix
- 11.1 Scope of the report
- 11.2 Inclusions and exclusions checklist
- Exhibit 129: Inclusions checklist
- Exhibit 130: Exclusions checklist
- 11.3 Currency conversion rates for US$
- Exhibit 131: Currency conversion rates for US$
- 11.4 Research methodology
- Exhibit 132: Research methodology
- Exhibit 133: Validation techniques employed for market sizing
- Exhibit 134: Information sources
- 11.5 List of abbreviations
- Exhibit 135: List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com
SOURCE Technavio
Share this article